Novel Anti-VEGF Drug Effective in Kidney Cancer
CHICAGO — An investigational drug targeting all three types of the vascular endothelial growth factor (VEGF) receptor was a lot more productive against advanced renal cell carcinoma than a current normal agent, researchers identified.
Read far more on MedPage Nowadays
Astellas & AVEO: Tivozanib Effectively Demonstrates the Longest Reported …
(ten) Renal cell carcinoma (RCC) accounts for around 90% of all kidney cancers, representing two-three% of all cancers worldwide.(five,6) It is nearly twice as prevalent in men as in girls, mainly in adults aged 50-80 years.(11) Cancer cells develop in the …
Read far more on MarketWatch (press release)
Pfizer Provides Topline Outcomes From Phase 3 Study Of Torisel(R) As Second …
NEW YORK, May 15, 2012 (Enterprise WIRE) — Pfizer Inc announced today that the Phase three INTORSECT (B1771003) study, evaluating TORISEL(R) (temsirolimus) in individuals with advanced renal cell carcinoma (RCC) whose illness had progressed on or immediately after …
Read far more on MarketWatch (press release)
Leave a Reply
You must be logged in to post a comment.